Evidence map›Paper›PMID 32973768›Full record

ArticleFrontiers in immunology2020

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.

Lauren M F Merlo, James B DuHadaway, James D Montgomery, Wei-Dan Peng, Peter J Murray, George C Prendergast, Andrew J Caton, Alexander J Muller, Laura Mandik-Nayak

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Lauren M F MerloLankenau Institute for Medical Research, Wynnewood, PA, United States.
James B DuHadawayLankenau Institute for Medical Research, Wynnewood, PA, United States.
James D MontgomeryLankenau Institute for Medical Research, Wynnewood, PA, United States.
Wei-Dan PengLankenau Institute for Medical Research, Wynnewood, PA, United States.
Peter J MurrayImmunoregulation Group, Max Planck Institute of Biochemistry, Martinsried, Germany.
George C PrendergastLankenau Institute for Medical Research, Wynnewood, PA, United States.
Andrew J CatonThe Wistar Institute, Philadelphia, PA, United States.
Alexander J MullerLankenau Institute for Medical Research, Wynnewood, PA, United States.
Laura Mandik-NayakLankenau Institute for Medical Research, Wynnewood, PA, United States.
Lankenau Institute for Medical Research · USMax Planck Institute of Biochemistry · DESidney Kimmel Cancer Center · USThe Wistar Institute · US

Funding

IDO2 Targeting in Pancreatic CancerR01CA191191 · NCI · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI PRENDERGAST, GEORGE C · 2015 to 2019
$2.0M
NCI NIH HHS R01 CA191191
6 · The paper itself

Abstract

Indoleamine-2,3-dioxygenase (IDO)1 and IDO2 are two closely related tryptophan catabolizing enzymes encoded by linked genes. The IDO pathway is also immunomodulatory, with IDO1 well-characterized as a mediator of tumor immune evasion. Due to its homology with IDO1, IDO2 has been proposed to have a similar immunoregulatory function. Indeed, IDO2, like IDO1, is necessary for the differentiation of regulatory T cells

Indexed as

AnimalsArthritis, ExperimentalB-LymphocytesHumansIndoleamine-Pyrrole 2,3,-DioxygenaseInflammationLymphocyte ActivationMiceMice, KnockoutOrthomyxoviridae InfectionsT-LymphocytesIDO1 protein, mouseIDO2 protein, mouseIndoleamine-Pyrrole 2,3,-DioxygenaseB cellsexperimental arthritisimmunizationinfluenzamurine model

Identifiers

PMID32973768
PMCPMC7461966
OpenAlexW3041699082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.